Instruction for use: Immunoglobulin antiallergicum fluidum

Dosage form: solution for injection

ATX

J06BC Other immunoglobulins

Pharmacological group:

Immunoglobulins

The nosological classification (ICD-10)

J30 Vasomotor and allergic rhinitis: Allergic rhinopathy; Allergic rhinosinusopathy; Allergic diseases of the upper respiratory tract; Allergic rhinitis; Allergic rhinitis seasonal; Vasomotor runny nose; Prolonged allergic rhinitis; All-year-round allergic rhinitis; All-season allergic rhinitis; Year-round or seasonal allergic rhinitis; All-the-year-round rhinitis of an allergic nature; Rhinitis vasomotor allergic; Exacerbation of pollinosis in the form of rhinoconjunctival syndrome; Acute allergic rhinitis; Edema of the nasal mucosa; Edema of the nasal mucosa; Edema of the nasal mucosa; Swelling of the nasal mucosa; Pollinosis; Permanent allergic rhinitis; Rhinoconjunctivitis; Rhinosinusitis; Rhinosinusopathy; Seasonal allergic rhinitis; Hay rhinitis; Chronic allergic rhinitis; Allergic diseases of the respiratory tract

J45.0 Asthma with predominance of the allergic component: Asthma of bakers; Allergic lung diseases; Bronchial asthma, professional; Aspirin Asthma; Asthma atopic; Asthma bronchial atopic; Atopic asthma; Atopic bronchial asthma; Persistent atopic bronchial asthma; Allergic diseases of the respiratory tract

L20 Atopic dermatitis: Allergic diseases of the skin; Allergic skin disease noninfectious etiology; Allergic skin disease etiology nemikrobnoy; Allergic skin diseases; Allergic skin lesions; Allergic reactions on the skin; atopic dermatitis; Allergic dermatosis; Allergic diathesis; Allergic itching dermatosis; Allergic skin disease; Allergic skin irritation; allergic Dermatitis; atopic Dermatitis; allergic dermatoses; exudative diathesis; Itchy atopic eczema Itchy allergic dermatosis; Allergic skin disease; Cutaneous allergic reaction to drugs and chemicals; Cutaneous reactions to medications; Skin and allergic disease; Acute eczema; common neurodermatitis; Chronic atopic dermatitis; Exudative diathesis

T78.4 Unspecified Allergy: Allergic reactions to insulin; Allergic reactions to insect stings; Allergic reactions similar to systemic lupus erythematosus; Allergic diseases; Allergic diseases of mucous membranes; Allergic diseases and conditions resulting from increased release of histamine; Allergic diseases of mucous membranes; Allergic symptoms; Allergic symptoms in the mucous membranes; Allergic reactions; Allergic reactions caused by insect bites; Allergic reactions; Allergic conditions; Allergic laryngeal edema; allergopathy; allergic conditions; Allergy; House dust allergy; Anaphylaxis; Cutaneous reactions to medications; Skin reaction to insect stings; Cosmetic allergy; Drug allergy; Acute allergic reaction; Laryngeal edema allergic genesis and background radiation; Food and drug allergy

Composition and release form

Immunologically active fraction of protein isolated from human donor plasma or serum. The active component is immunoglobulin G (IgG). The protein concentration is 100 mg / ml; Stabilizer-glycine up to 22.5 mg / ml. Liquid in ampoules of 1 ml (1 dose), in the package 10 pcs.

Characteristic

Transparent or slightly opalescent liquid, colorless or with a weak yellow color. Does not contain preservative and antibiotics, virologically safe.

Pharmachologic effect

Mode action - antiallergic.

Indications for the preparation Immunoglobulin antiallergicum fluidum

Allergic diseases of mild and moderate severity in the stage of remission in adults and children from 1 year, pollinosis, allergic dermatoses, atopic bronchial asthma.

Contraindications

Hypersensitivity, age (up to 1 year).

Side effects

Perhaps a minor and short-term exacerbation of the underlying disease, hyperemia at the injection site, an increase in temperature (up to 37.5 ° C).

Dosing and Administration

IM. Children under 5 years - 1 ml (1 dose) 5 times at intervals of 4 days. Children older than 5 years and adults are given 2 ml of the drug at the same frequency.

Precautionary measures

After the introduction, patients should be monitored for 30 minutes (the possibility of developing allergic reactions). Preparations should be made for anti-shock therapy. The preparation is not suitable for use in ampoules with broken integrity and marking, with changing physical properties (turbidity, intense staining, presence of non-breakable flakes), expired shelf life, improper storage.

Storage conditions of the drug Immunoglobulin antiallergicum fluidum

In dry, the dark place at a temperature of 2-10 ° C.

Keep out of the reach of children.

Shelf life of the drug Immunoglobulin antiallergicum fluidum

2 years.

Do not use after the expiry date printed on the package.